-
Ticagrelor, sold
under the
brand name
Brilinta among others, is a
medication used for the
prevention of stroke,
heart attack and
other events in people...
- in-vivo to
inhibit the P2Y12 receptor. On the
other hand,
novel drugs like
ticagrelor (Brilinta®) and
cangrelor (Kengrexal®) are non-thienopyridines and reversibly...
- neuroprotection. The
drugs clopidogrel (Plavix),
prasugrel (Efient, Effient),
ticagrelor (Brilinta), and
cangrelor (Kengreal) bind to this
receptor and are marketed...
-
order to
avoid confusion with the blood-thinning
medication Brilinta (
ticagrelor).
Other brand names include Torvox, Vantaxa, Voxigain, and Trivoxetin...
- of
aspirin plus an ADP/P2Y
inhibitor (such as clopidogrel, prasugrel,
ticagrelor, or another) is used to
obtain greater effectiveness than with either...
-
advent of
newer and
safer antiplatelet drugs such as
clopidogrel and
ticagrelor, its use
remained limited. It was
patented in 1973 and
approved for medical...
- with
presumed ACS are
typically treated with aspirin,
clopidogrel or
ticagrelor, nitroglycerin, and, if the
chest discomfort persists, morphine. Other...
- indefinitely, as well as
another antiplatelet agent such as
clopidogrel or
ticagrelor ("dual
antiplatelet therapy" or DAPT) for up to
twelve months. If someone...
-
trials to
function as a
reversal agent for the anti–blood
clotting drug
ticagrelor (which acts as a P2Y12
inhibitor and is sold
under the
brand name Brilinta...
-
Sebelipase alfa
Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab
Trastuzumab deruxtecan Vandetanib Vaxzevria Ximelagatran...
